{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:13Z","timestamp":1792804153531,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL156986"],"award-info":[{"award-number":["R01 HL156986"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.peptides.2021.170733","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T11:26:43Z","timestamp":1640777203000},"page":"170733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The renin-angiotensin system and cardiovascular autonomic control in aging"],"prefix":"10.1016","volume":"150","author":[{"given":"Amanda J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1380-6017","authenticated-orcid":false,"given":"Amy C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.peptides.2021.170733_bib0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170733_bib0010","series-title":"World Population Ageing 2019","author":"United Nations DoEaSA, Population Division","year":"2020"},{"issue":"March (3)","key":"10.1016\/j.peptides.2021.170733_bib0015","article-title":"The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover","volume":"282","author":"Esler","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"November 1","key":"10.1016\/j.peptides.2021.170733_bib0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1469-7793.2000.00407.x","article-title":"Human ageing and the sympathoadrenal system","author":"Seals","year":"2000","journal-title":"J Physiol."},{"issue":"December (5)","key":"10.1016\/j.peptides.2021.170733_bib0025","first-page":"S29","article-title":"Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease","volume":"17","author":"Franklin","year":"1999","journal-title":"J. Hypertens. Suppl."},{"issue":"6","key":"10.1016\/j.peptides.2021.170733_bib0030","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1152\/japplphysiol.00601.2003","article-title":"Invited review: aging and the cardiovascular system","volume":"95","author":"Ferrari","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.peptides.2021.170733_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13293-016-0110-x","article-title":"Sex- and age-related differences in arterial pressure and albuminuria in mice","volume":"7","author":"Barsha","year":"2016","journal-title":"Biol. Sex Differ."},{"issue":"11","key":"10.1016\/j.peptides.2021.170733_bib0040","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCRESAHA.114.302524","article-title":"The autonomic nervous system and hypertension","volume":"114","author":"Mancia","year":"2014","journal-title":"Circ. Res."},{"issue":"August (4)","key":"10.1016\/j.peptides.2021.170733_bib0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11906-013-0362-3","article-title":"Current concepts in orthostatic hypotension management","volume":"15","author":"Arnold","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"issue":"11","key":"10.1016\/j.peptides.2021.170733_bib0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000028819.64790.BE","article-title":"Aging and forearm postjunctional alpha-adrenergic vasoconstriction in healthy men","volume":"106","author":"Dinenno","year":"2002","journal-title":"Circulation"},{"issue":"November 1","key":"10.1016\/j.peptides.2021.170733_bib0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-7793.2001.00977.x","article-title":"Reductions in basal limb blood flow and vascular conductance with human ageing: role for augmented alpha-adrenergic vasoconstriction","author":"Dinenno","year":"2001","journal-title":"J Physiol"},{"issue":"10","key":"10.1016\/j.peptides.2021.170733_bib0060","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00584.2014","article-title":"Muller MD. Beta-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men","volume":"307","author":"Ross","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"July (1)","key":"10.1016\/j.peptides.2021.170733_bib0065","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1152\/ajpregu.00031.2007","article-title":"Effect of aging on baroreflex function in humans","volume":"293","author":"Monahan","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"April (2)","key":"10.1016\/j.peptides.2021.170733_bib0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.peptides.2021.170733_bib0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41232-016-0018-1","article-title":"Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes","volume":"36","author":"Kamo","year":"2016","journal-title":"Inflamm Regen"},{"issue":"July (7)","key":"10.1016\/j.peptides.2021.170733_bib0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.peptides.2021.170733_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fphys.2014.00439","article-title":"The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance","volume":"5","author":"Vajapey","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.peptides.2021.170733_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586314","article-title":"Brain renin-angiotensin system at the intersect of physical and cognitive frailty","volume":"14","author":"Cosarderelioglu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"January 24","key":"10.1016\/j.peptides.2021.170733_bib0095","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.peptides.2021.170733_bib0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0105","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/en.2003-0150","article-title":"Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system","volume":"144","author":"Lavoie","year":"2003","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.peptides.2021.170733_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0361-9230(99)00237-3","article-title":"Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata","volume":"51","author":"Averill","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.peptides.2021.170733_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7453161","article-title":"Angiotensin II attenuates the bioactivities of human endothelial progenitor cells via downregulation of beta2-Adrenergic receptor","volume":"2018","author":"Lee","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.peptides.2021.170733_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2016.11.027","article-title":"Angiotensin type 1A receptor regulates beta-arrestin binding of the beta2-adrenergic receptor via heterodimerization","volume":"442","author":"Toth","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"March (3)","key":"10.1016\/j.peptides.2021.170733_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.HYP.31.3.747","article-title":"Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac beta-adrenergic signal transduction","volume":"31","author":"Bohm","year":"1998","journal-title":"Hypertension"},{"issue":"March (1)","key":"10.1016\/j.peptides.2021.170733_bib0130","first-page":"19","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemarie","year":"2010","journal-title":"J. Renin. Syst."},{"issue":"January (1 Pt 2)","key":"10.1016\/j.peptides.2021.170733_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"issue":"10A","key":"10.1016\/j.peptides.2021.170733_bib0140","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9149(99)00727-4","article-title":"Angiotensin II receptor blockers: review of the binding characteristics","volume":"84","author":"Siragy","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"February (2)","key":"10.1016\/j.peptides.2021.170733_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/HYPERTENSIONAHA.107.101717","article-title":"Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats","volume":"51","author":"Gao","year":"2008","journal-title":"Hypertension"},{"issue":"October (10)","key":"10.1016\/j.peptides.2021.170733_bib0150","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/ajh\/hpu044","article-title":"Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure","volume":"27","author":"Gao","year":"2014","journal-title":"Am. J. Hypertens."},{"issue":"April (4)","key":"10.1016\/j.peptides.2021.170733_bib0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41440-018-0196-0","article-title":"Importance of AT1 and AT2 receptors in the nucleus of the solitary tract in cardiovascular responses induced by a high-fat diet","volume":"42","author":"Speretta","year":"2019","journal-title":"Hypertens. Res."},{"issue":"December","key":"10.1016\/j.peptides.2021.170733_bib0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.npep.2016.06.006","article-title":"Overexpression of AT2R in the solitary-vagal complex improves baroreflex in the spontaneously hypertensive rat","volume":"60","author":"Ruchaya","year":"2016","journal-title":"Neuropeptides"},{"issue":"March (3)","key":"10.1016\/j.peptides.2021.170733_bib0165","first-page":"580","article-title":"Hyporeninemic normoaldosteronism in severe autonomic failure","volume":"76","author":"Biaggioni","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.peptides.2021.170733_bib0170","doi-asserted-by":"crossref","first-page":"F583","DOI":"10.1152\/ajprenal.00246.2015","article-title":"Renal denervation for the treatment of resistant hypertension: review and clinical perspective","volume":"309","author":"Iliescu","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"May (3)","key":"10.1016\/j.peptides.2021.170733_bib0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3904\/kjim.2014.29.3.291","article-title":"The renin-angiotensin system and aging in the kidney","volume":"29","author":"Yoon","year":"2014","journal-title":"Korean J. Intern. Med."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ki.1975.120","article-title":"Effect on aging on plasma renin and aldosterone in normal man","volume":"8","author":"Weidmann","year":"1975","journal-title":"Kidney Int."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0185","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1681\/ASN.V651459","article-title":"Aldosterone responses to hyperkalemia in healthy elderly humans","volume":"6","author":"Mulkerrin","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"issue":"July (1)","key":"10.1016\/j.peptides.2021.170733_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/HYPERTENSIONAHA.107.108985","article-title":"Dahl memorial lecture: the renin-angiotensin system and aging","volume":"52","author":"Diz","year":"2008","journal-title":"Hypertension"},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0195","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ki.1988.113","article-title":"Catecholamine receptor binding in rat kidney: effect of aging","volume":"33","author":"Galbusera","year":"1988","journal-title":"Kidney Int."},{"issue":"February (2)","key":"10.1016\/j.peptides.2021.170733_bib0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.113.02217","article-title":"Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity","volume":"63","author":"Nguyen","year":"2014","journal-title":"Hypertension"},{"issue":"February (2)","key":"10.1016\/j.peptides.2021.170733_bib0205","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jcem-62-2-384","article-title":"Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma","volume":"62","author":"Tsunoda","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"August (8)","key":"10.1016\/j.peptides.2021.170733_bib0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1532-5415.1981.tb01245.x","article-title":"Effect of age on active and inactive plasma renin in normal subjects and in patients with essential hypertension","volume":"29","author":"Nakamaru","year":"1981","journal-title":"J. Am. Geriatr. Soc."},{"issue":"July (7)","key":"10.1016\/j.peptides.2021.170733_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0895-7061(96)00022-2","article-title":"Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age","volume":"9","author":"Trenkwalder","year":"1996","journal-title":"Am. J. Hypertens."},{"issue":"July (7)","key":"10.1016\/j.peptides.2021.170733_bib0220","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/hr.2014.46","article-title":"Serum soluble (pro)renin receptor levels in patients with essential hypertension","volume":"37","author":"Morimoto","year":"2014","journal-title":"Hypertens. Res."},{"issue":"July","key":"10.1016\/j.peptides.2021.170733_bib0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.peptides.2014.04.021","article-title":"Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue","volume":"57","author":"Rubio-Ruiz","year":"2014","journal-title":"Peptides"},{"issue":"May (5)","key":"10.1016\/j.peptides.2021.170733_bib0230","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/HYPERTENSIONAHA.109.147058","article-title":"Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension","volume":"55","author":"Wray","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170733_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13293-017-0128-8","article-title":"Sex differences in the aging pattern of renin-angiotensin system serum peptidases","volume":"8","author":"Fernandez-Atucha","year":"2017","journal-title":"Biol. Sex Differ."},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0240","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/HYPERTENSIONAHA.108.111294","article-title":"Angiotensin II in the elderly: impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics","volume":"51","author":"Wray","year":"2008","journal-title":"Hypertension"},{"issue":"August (4)","key":"10.1016\/j.peptides.2021.170733_bib0245","first-page":"552","article-title":"Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects","volume":"94","author":"Takeda","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"July (1)","key":"10.1016\/j.peptides.2021.170733_bib0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/HYPERTENSIONAHA.106.086587","article-title":"Angiotensin receptors and aging","volume":"50","author":"Carey","year":"2007","journal-title":"Hypertension"},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0255","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.HYP.0000073843.56046.45","article-title":"Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates","volume":"41","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170733_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6731093","article-title":"Age-associated changes in the vascular renin-angiotensin system in mice","volume":"2016","author":"Yoon","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"May (3)","key":"10.1016\/j.peptides.2021.170733_bib0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/14796678.4.3.237","article-title":"Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function","volume":"4","author":"Diz","year":"2008","journal-title":"Future Cardiol."},{"issue":"December (12)","key":"10.1016\/j.peptides.2021.170733_bib0270","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1152\/japplphysiol.00569.2012","article-title":"The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen","volume":"15","author":"Arnold","year":"2012","journal-title":"J Appl Physiol (1985)"},{"issue":"14","key":"10.1016\/j.peptides.2021.170733_bib0275","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0280","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0285","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.118.10918","article-title":"The meaning of mas","volume":"72","author":"Bader","year":"2018","journal-title":"Hypertension"},{"issue":"Febuary (2)","key":"10.1016\/j.peptides.2021.170733_bib0290","article-title":"Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats","volume":"296","author":"Giani","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0295","article-title":"Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats","volume":"284","author":"Sampaio","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"January (1)","key":"10.1016\/j.peptides.2021.170733_bib0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"issue":"February (2)","key":"10.1016\/j.peptides.2021.170733_bib0305","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"April (4)","key":"10.1016\/j.peptides.2021.170733_bib0310","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/HYPERTENSIONAHA.110.149815","article-title":"Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling","volume":"55","author":"Santiago","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.peptides.2021.170733_bib0315","doi-asserted-by":"crossref","first-page":"H980","DOI":"10.1152\/ajpheart.00768.2016","article-title":"Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism","volume":"312","author":"Guo","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"March (3)","key":"10.1016\/j.peptides.2021.170733_bib0320","article-title":"Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats","volume":"298","author":"Giani","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"May (5)","key":"10.1016\/j.peptides.2021.170733_bib0325","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/HYPERTENSIONAHA.113.01847","article-title":"Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats","volume":"63","author":"Guimaraes","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.peptides.2021.170733_bib0330","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00075.2012","article-title":"Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats","volume":"303","author":"Guimaraes","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0335","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.HYP.0000143850.73831.9d","article-title":"Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats","volume":"44","author":"Gironacci","year":"2004","journal-title":"Hypertension"},{"issue":"September (3 Pt 2)","key":"10.1016\/j.peptides.2021.170733_bib0340","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.HYP.30.3.549","article-title":"Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats","volume":"30","author":"Britto","year":"1997","journal-title":"Hypertension"},{"issue":"February (2)","key":"10.1016\/j.peptides.2021.170733_bib0345","article-title":"Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed","volume":"298","author":"Byku","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"October (4)","key":"10.1016\/j.peptides.2021.170733_bib0350","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.HYP.24.4.457","article-title":"Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria","volume":"24","author":"Gironacci","year":"1994","journal-title":"Hypertension"},{"issue":"September (3)","key":"10.1016\/j.peptides.2021.170733_bib0355","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain","volume":"293","author":"Becker","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"February","key":"10.1016\/j.peptides.2021.170733_bib0360","article-title":"Angiotensin-(1-7) induces beige fat thermogenesis through the Mas receptor","volume":"103","author":"Vargas-Castillo","year":"2020","journal-title":"Metabolism"},{"issue":"Jul-Sep(3)","key":"10.1016\/j.peptides.2021.170733_bib0365","article-title":"Age-related changes in vascular responses to angiotensin-(1-7) in female mice","volume":"19","author":"Costa-Fraga","year":"2018","journal-title":"J. Renin. Syst."},{"key":"10.1016\/j.peptides.2021.170733_bib0370","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/192567","article-title":"Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated rats","volume":"2012","author":"Bosnyak","year":"2012","journal-title":"Int. J. Hypertens."},{"issue":"14","key":"10.1016\/j.peptides.2021.170733_bib0375","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/ijms21145131","article-title":"Angiotensin-(1-7) improves integrated cardiometabolic function in aged mice","volume":"21","author":"Miller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"January (1)","key":"10.1016\/j.peptides.2021.170733_bib0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248413501018","article-title":"Renin-angiotensin system blocking drugs","volume":"19","author":"Robles","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajh\/hpw012","article-title":"Sympathomodulatory effects of antihypertensive drug treatment","volume":"29","author":"Grassi","year":"2016","journal-title":"Am. J. Hypertens."},{"issue":"May (5)","key":"10.1016\/j.peptides.2021.170733_bib0390","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.HYP.37.5.1309","article-title":"Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7)","volume":"37","author":"Heringer-Walther","year":"2001","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.peptides.2021.170733_bib0395","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.CIR.96.4.1173","article-title":"Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure","volume":"96","author":"Grassi","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.peptides.2021.170733_bib0400","doi-asserted-by":"crossref","first-page":"E1204","DOI":"10.1152\/ajpendo.00281.2018","article-title":"Angiotensin-(1-7) contributes to insulin-sensitizing effects of angiotensin-converting enzyme inhibition in obese mice","volume":"315","author":"Loloi","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"September (3)","key":"10.1016\/j.peptides.2021.170733_bib0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2012.05.001","article-title":"Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes","volume":"66","author":"Yousif","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0410","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"issue":"May (5)","key":"10.1016\/j.peptides.2021.170733_bib0415","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FJC.0b013e31821324b6","article-title":"Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester","volume":"57","author":"Benter","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.peptides.2021.170733_bib0420","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.regpep.2004.12.027","article-title":"Protective effect of the inhibition of the renin-angiotensin system on aging","volume":"128","author":"Basso","year":"2005","journal-title":"Regul. Pept."},{"issue":"January (1)","key":"10.1016\/j.peptides.2021.170733_bib0425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/hr.2012.161","article-title":"Brain renin-angiotensin system in the nexus of hypertension and aging","volume":"36","author":"Arnold","year":"2013","journal-title":"Hypertens. Res."},{"issue":"2","key":"10.1016\/j.peptides.2021.170733_bib0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00002512-200623020-00004","article-title":"The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension","volume":"23","author":"Thomas","year":"2006","journal-title":"Drugs Aging"},{"issue":"July (7)","key":"10.1016\/j.peptides.2021.170733_bib0435","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/gerona\/59.7.M713","article-title":"Are angiotensin-converting enzyme inhibitors indicated for the routine treatment of elderly heart failure patients?","volume":"59","author":"Rich","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"July (7)","key":"10.1016\/j.peptides.2021.170733_bib0440","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2215\/CJN.08611209","article-title":"Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations","volume":"5","author":"Turgut","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"December (6)","key":"10.1016\/j.peptides.2021.170733_bib0445","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/fcp.12313","article-title":"The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case\/noncase study in vigibase","volume":"31","author":"Alharbi","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"November (11)","key":"10.1016\/j.peptides.2021.170733_bib0450","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2010.06.014","article-title":"Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians\u2019 Desk Reference","volume":"123","author":"Bangalore","year":"2010","journal-title":"Am. J. Med."},{"issue":"April (7)","key":"10.1016\/j.peptides.2021.170733_bib0455","article-title":"Central infusion of aliskiren prevents sympathetic hyperactivity and hypertension in Dahl salt-sensitive rats on high salt intake","volume":"302","author":"Huang","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.peptides.2021.170733_bib0460","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6060061","article-title":"Renin inhibition with Aliskiren: a decade of clinical experience","volume":"6","author":"Pantzaris","year":"2017","journal-title":"J. Clin. Med."},{"issue":"September (9)","key":"10.1016\/j.peptides.2021.170733_bib0465","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/jhh.2009.107","article-title":"Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial","volume":"24","author":"Duprez","year":"2010","journal-title":"J. Hum. Hypertens."},{"issue":"July (26)","key":"10.1016\/j.peptides.2021.170733_bib0470","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/eurheartj\/ehu079","article-title":"Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial","volume":"35","author":"Teo","year":"2014","journal-title":"Eur. Heart J."},{"issue":"June (6)","key":"10.1016\/j.peptides.2021.170733_bib0475","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/ATVBAHA.116.307518","article-title":"Vascular actions of angiotensin 1-7 in the human microcirculation: novel role for telomerase","volume":"36","author":"Durand","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"January (1)","key":"10.1016\/j.peptides.2021.170733_bib0480","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1152\/ajpregu.00221.2019","article-title":"Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia","volume":"318","author":"Stanhewicz","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"April (4)","key":"10.1016\/j.peptides.2021.170733_bib0485","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/clinchem\/47.4.726","article-title":"Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood","volume":"47","author":"Nussberger","year":"2001","journal-title":"Clin. Chem."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0490","article-title":"Effects of truncated angiotensins in humans after double blockade of the renin system","volume":"285","author":"Plovsing","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"July (1)","key":"10.1016\/j.peptides.2021.170733_bib0495","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.38.1.90","article-title":"Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension","volume":"38","author":"Sasaki","year":"2001","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.peptides.2021.170733_bib0500","first-page":"125","article-title":"Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy","volume":"3","author":"Schindler","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"issue":"October (4)","key":"10.1016\/j.peptides.2021.170733_bib0505","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/HYPERTENSIONAHA.113.01814","article-title":"Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion","volume":"62","author":"van Twist","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.peptides.2021.170733_bib0510","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13293-019-0251-9","article-title":"Sex differences in metabolic effects of angiotensin-(1-7) treatment in obese mice","volume":"10","author":"White","year":"2019","journal-title":"Biol. Sex Differ."},{"issue":"5","key":"10.1016\/j.peptides.2021.170733_bib0515","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10286-020-00720-2","article-title":"Sex differences in cardiovascular actions of the renin-angiotensin system","volume":"30","author":"Medina","year":"2020","journal-title":"Clin. Auton. Res."},{"issue":"November (5)","key":"10.1016\/j.peptides.2021.170733_bib0520","article-title":"Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects","volume":"275","author":"Matsukawa","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"June (3)","key":"10.1016\/j.peptides.2021.170733_bib0525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11906-012-0260-0","article-title":"Hypertension in postmenopausal women","volume":"14","author":"Lima","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"issue":"May (5)","key":"10.1016\/j.peptides.2021.170733_bib0530","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1113\/EP088452","article-title":"Forearm vasodilatation to a beta2 -adrenergic receptor agonist in premenopausal and postmenopausal women","volume":"105","author":"Harvey","year":"2020","journal-title":"Exp. Physiol."},{"issue":"9","key":"10.1016\/j.peptides.2021.170733_bib0535","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4330\/wjc.v6.i9.878","article-title":"African Americans, hypertension and the renin angiotensin system","volume":"6","author":"Williams","year":"2014","journal-title":"World J. Cardiol."},{"issue":"January (1)","key":"10.1016\/j.peptides.2021.170733_bib0540","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.jhh.1001127","article-title":"Why is plasma renin activity lower in populations of African origin?","volume":"15","author":"Sagnella","year":"2001","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"10.1016\/j.peptides.2021.170733_bib0545","doi-asserted-by":"crossref","first-page":"R234","DOI":"10.1152\/ajpregu.00091.2019","article-title":"Neural control of cardiovascular function in black adults: implications for racial differences in autonomic regulation","volume":"318","author":"Drew","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:31:14Z","timestamp":1759311074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":109,"alternative-id":["S0196978121002412"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170733","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The renin-angiotensin system and cardiovascular autonomic control in aging","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170733"}}